G. Bradley Cole, CFO at GENOMIC HEALTH INC (GHDX), sold 25,000 shares at $81.48 ($2.0M) on 2019-02-12, disclosed to the SEC on 2019-02-14.
Seasonal sale ($2.0M) by CFO — this insider has traded GHDX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.35 | 5,000 | $402K | 19.8% |
| 2 | $80.89 | 5,935 | $480K | 23.7% |
| 3 | $80.89 | 5,935 | $480K | 23.7% |
| 4 | $81.48 | 4,065 | $331K | 16.4% |
| 5 | $81.48 | 4,065 | $331K | 16.4% |
| Total | $80.97 avg | 25,000 |
| $2.0M |
| 100% |
| Filing → |
| EXAS | SELL | 2020-02-21 | $2.7M | — | Filing → |
| EXAS | SELL | 2020-01-17 | $903K | — | Filing → |
| EXAS | SELL | 2019-11-25 | $4.5M | — | Filing → |